Shree Ganesh Remedies (Small Cap - High Growth) Share Target 2026, 2027 To 2035
|
Shree Ganesh Remedies Limited |
|||
|
Price: ₹568.85 (-5.26%) | ||
| 52 Week Low: ₹381.10 52 Week High: ₹665.00 |
|||
| Market Capital: 669.8 Crore (Small-cap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Shree Ganesh Remedies Share Price Target For 2026
- 1.1.1: Shree Ganesh Remedies Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Shree Ganesh Remedies Share Price Target For 2027
- 1.2.1: Shree Ganesh Remedies Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Shree Ganesh Remedies Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Shree Ganesh Remedies Financial Performance
- 3.0.1: Is Shree Ganesh Remedies A Good Buy For Long Term?
Shree Ganesh Remedies, a Small Cap company has delivered 64.1% returns in 3-year with 47.7% profit margin, making it a High Growth stock.
To predict the Shree Ganesh Remedies's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Shree Ganesh Remedies Share Price Target For 2026
The line chart displays the monthly closing prices of Shree Ganesh Remedies with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Shree Ganesh Remedies shares in 2026, see the table below.
Shree Ganesh Remedies Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 686.51 (+20.68%) | Volatility: BB Upper |
| 2026 Target 2 | 646.63 (+13.67%) | Volatility: ATR T1 |
| 2026 Target 1 | 603.72 (+6.12%) | Trend: EMA9 |
| Current Price | 568.85 | Shree Ganesh Remedies's share price as of 15 Jun 2026 |
| Stop Loss 1 | 556.55 (-2.17%) | 38.20% Weekly Fib Retrace |
| Stop Loss 2 | 548.46 (-3.59%) | Volatility: BB Lower |
| Stop Loss 3 | 547.93 (-3.68%) | Trend: SMA50 |
Short-Term Technical Outlook
Current Technical Position: Shree Ganesh Remedies is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹547.93 serves as the nearest technical reference point.
Historical Returns: 3-month: +19.76% | 6-month: +24.86% | 1-year: -2.45%
Shree Ganesh Remedies Share Price Target For 2027
The line chart displays the monthly closing prices of Shree Ganesh Remedies with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Shree Ganesh Remedies shares in 2027, see the table below.
Shree Ganesh Remedies Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 686.51 (+20.68%) | Volatility: BB Upper |
| 2027 Target 2 | 646.63 (+13.67%) | Volatility: ATR T1 |
| 2027 Target 1 | 603.72 (+6.12%) | Trend: EMA9 |
| Current Price | 568.85 | Shree Ganesh Remedies's share price as of 15 Jun 2026 |
| Stop Loss 1 | 556.55 (-2.17%) | 38.20% Weekly Fib Retrace |
| Stop Loss 2 | 548.46 (-3.59%) | Volatility: BB Lower |
| Stop Loss 3 | 547.93 (-3.68%) | Trend: SMA50 |
Long-Term Technical Outlook
52-Week Range Analysis: Shree Ganesh Remedies is currently trading at 66.1% of its 52-week range (₹381.1 - ₹665).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: -2.45% | 3-year: +64.1% | 5-year: +49.51%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Shree Ganesh Remedies Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹568.85 | ||
| 2026 | ₹670.90 | +17.939702909379% | ₹680.96 |
| 2027 | ₹960.79 | +43.209122074825% | ₹975.20 |
| 2028 | ₹1,220.49 | +27.029840027477% | ₹1,238.80 |
| 2029 | ₹1,410.28 | +15.550311760031% | ₹1,431.43 |
| 2030 | ₹1,754.74 | +24.424936891965% | ₹1,781.06 |
| 2031 | ₹2,248.20 | +28.121545072204% | ₹2,281.92 |
| 2032 | ₹2,713.67 | +20.704118850636% | ₹2,754.38 |
| 2033 | ₹3,300.52 | +21.625695091887% | ₹3,350.03 |
| 2034 | ₹3,968.98 | +20.253172227407% | ₹4,028.51 |
| 2035 | ₹4,516.57 | +13.796743747764% | ₹4,584.32 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Shree Ganesh Remedies Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 595.38 Crore | Market valuation of Shree Ganesh Remedies's shares. |
| Revenue (TTM) | 90.21 Crore | Total revenue generated by Shree Ganesh Remedies over the past twelve months. |
| Net Income (TTM) | +17.02 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 25.08% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 47.72% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-16.29% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.38 | Company's total debt divided by total shareholder equity. |
| Total Debt | 38.18 Crore | Sum of Shree Ganesh Remedies's current & long-term financial obligations. |
Is Shree Ganesh Remedies A Good Buy For Long Term?
Shree Ganesh Remedies is a smallcap stock with strong financial performance. In the last 12 months (TTM), it generated a revenue of 90.21 Crore and a net profit of 17.02 Crore. The company has a profit margin of 47.72%, indicating efficient operations. However, it has a debt of 38.18 Crore, which investors should consider. With a past 5-year return of 1140.35%, the stock has shown impressive growth potential. Overall, it could be considered an average buy for long-term investment, with the potential for moderate returns.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
